Butterfly Network (BFLY) Cash from Investing Activities (2020 - 2026)
Butterfly Network recorded quarterly Cash from Investing Activities of -$950000.0 in Q1 2026, up 12.28% quarter-over-quarter from -$1.1 million in Q4 2025, and down 169.12% year-over-year from $1.4 million in Q1 2025.
Butterfly Network's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$950000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 169.12% year-over-year to -$950000.0; the TTM figure through Mar 2026 stood at -$3.9 million (down 110.62% YoY), while the FY2025 annual figure was -$3.3 million, down 25.96% from the prior year.
- Cash from Investing Activities came in at -$950000.0 for Q1 2026 at Butterfly Network, up from -$1.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $74.9 million in Q1 2023 to a low of -$79.7 million in Q3 2022.
- A 5-year average of -$1.8 million and a median of -$1.0 million in 2025 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities soared 1761.23% in 2023 and slumped 169.12% in 2026, its largest moves.
- Butterfly Network's Cash from Investing Activities stood at -$2.5 million in 2022, then slipped by 1.25% to -$2.5 million in 2023, then jumped by 83.76% to -$408000.0 in 2024, then slumped by 165.44% to -$1.1 million in 2025, then rose by 12.28% to -$950000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$950000.0, -$1.1 million, and -$1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Butterfly Network | 1.17 Bn | 1.04 Bn | 18.29 Mn | -950,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -950,000.00 |
| Mar 31, 2026 | -950,000.00 |
| Dec 31, 2025 | -1.08 Mn |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Jun 30, 2025 | -896,000.00 |
| Jun 30, 2025 | -896,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Mar 31, 2025 | -353,000.00 |
| Dec 31, 2024 | -408,000.00 |
| Dec 31, 2024 | -408,000.00 |
| Sep 30, 2024 | -413,000.00 |
| Sep 30, 2024 | -413,000.00 |
| Jun 30, 2024 | -699,000.00 |
| Jun 30, 2024 | -699,000.00 |
| Mar 31, 2024 | -1.14 Mn |
| Mar 31, 2024 | -1.14 Mn |
| Dec 31, 2023 | -2.51 Mn |
| Dec 31, 2023 | -2.51 Mn |
| Sep 30, 2023 | -1.05 Mn |
| Sep 30, 2023 | -1.05 Mn |
| Jun 30, 2023 | -881,000.00 |
| Jun 30, 2023 | -881,000.00 |
| Mar 31, 2023 | 74.86 Mn |
| Mar 31, 2023 | 74.86 Mn |
| Dec 31, 2022 | -2.48 Mn |
| Dec 31, 2022 | -2.48 Mn |
| Sep 30, 2022 | -79.72 Mn |
| Sep 30, 2022 | -79.72 Mn |
| Jun 30, 2022 | -7.07 Mn |
| Jun 30, 2022 | -7.07 Mn |
| Mar 31, 2022 | -4.51 Mn |
| Mar 31, 2022 | -4.51 Mn |
| Dec 31, 2021 | 309.90 Mn |
| Dec 31, 2021 | 309.90 Mn |
| Sep 30, 2021 | 172.57 Mn |
| Sep 30, 2021 | 172.57 Mn |
| Jun 30, 2021 | 35.85 Mn |
| Jun 30, 2021 | 35.85 Mn |
| Mar 31, 2021 | -528.20 Mn |
| Mar 31, 2021 | -528.20 Mn |
| Dec 31, 2020 | 221,000.00 |
| Dec 31, 2020 | 221,000.00 |
| Sep 30, 2020 | -689,000.00 |
| Sep 30, 2020 | -689,000.00 |
| Jun 30, 2020 | -1.43 Mn |
| Jun 30, 2020 | -1.43 Mn |
| Mar 31, 2020 | -480,000.00 |
| Mar 31, 2020 | -480,000.00 |